SCHEMBL17237703

SCHEMBL17237703

CCCCCCCC/C=C\CCCCCCCCOCC(=O)COCCCCCCCC/C=C\CCCCCCCC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.59
CES2 O00748 2/20 0.58
FAAH O00519 3/20 0.54
TERT O14746 3/20 0.52
PTPN1 P18031 3/20 0.52
CYP1A2 P05177 2/20 0.52
MAPT P10636 2/20 0.52
CYP2C19 P33261 2/20 0.52
BLM P54132 2/20 0.52
HSD17B10 Q99714 2/20 0.52
FABP4 P15090 2/20 0.52
PPARG P37231 2/20 0.52
KMT2A Q03164 2/20 0.52
PPARD Q03181 2/20 0.52
PPARA Q07869 2/20 0.52
GMNN O75496 1/20 0.52
USP2 O75604 1/20 0.52
LMNA P02545 1/20 0.52
POLB P06746 1/20 0.52
CYP2C9 P11712 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17237707 1.00 EPHX2 (0.59) EPHX2CES2FAAHTERTPTPN1
SCHEMBL3487344 0.95 ALDH1A1 (0.56) HSD17B10FABP4PPARGPPARDPPARA
SCHEMBL3487349 0.95 ALDH1A1 (0.56) HSD17B10FABP4PPARGPPARDPPARA
SCHEMBL15295117 0.91 PPARG (0.70) FAAHTERTPTPN1CYP1A2MAPT
SCHEMBL2865178 0.88 CES2 (0.72) CES2FAAHMAPTKMT2AUSP2
SCHEMBL15295118 0.88 EPHX2 (0.58) EPHX2FAAHTERTPTPN1CYP1A2
SCHEMBL15295170 0.88 EPHX2 (0.58) EPHX2FAAHTERTPTPN1CYP1A2
SCHEMBL903055 0.87 ALDH1A1 (0.59) HSD17B10FABP4PPARGPPARDPPARA
SCHEMBL2430018 0.86 CES2 (0.68) EPHX2CES2FAAHMAPTKMT2A
SCHEMBL1627821 0.84 EPHX2 (0.71) EPHX2CES2FAAHTERTPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150321992-A1 TRIACYLGLYCEROL OLIGOMERS TRENT UNIVERSITY (CA) 2015-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150321992-A1 TRIACYLGLYCEROL OLIGOMERS SQLE, DGAT2, PNLIP EPHX2 805/4885CES2 318/4885FAAH 693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.